Phaarmasia Limited (BOM:523620)
99.75
+4.75 (5.00%)
At close: Jun 17, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 680.99 million as of June 17, 2026. Its market cap has increased by 222.09% in one year.
Market Cap
680.99M
Enterprise Value
582.36M
Revenue
472.08M
Ranking
n/a
PE Ratio
3.88
Stock Price
99.75
Market Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 680.99M, an increase of 4,869.93%. That is a compound annual growth rate of 14.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 680.99M | -11.52% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 900.66M |
| Makers Laboratories | 873.85M |
| Amwill Health Care | 853.15M |
| Source Natural Foods and Herbal Supplements | 710.32M |
| Asston Pharmaceuticals | 702.57M |
| Onyx Biotec | 688.12M |
| Biofil Chemicals and Pharmaceuticals | 571.21M |
| Shelter Pharma | 488.44M |